KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Intangibles (2016 - 2025)

Biogen (BIIB) has 15 years of Intangibles data on record, last reported at $8.2 billion in Q2 2024.

  • For Q2 2024, Intangibles changed N/A year-over-year to $8.2 billion; the TTM value through Jun 2024 reached $8.2 billion, changed N/A, while the annual FY2022 figure was $1.9 billion, 16.71% down from the prior year.
  • Intangibles reached $8.2 billion in Q2 2024 per BIIB's latest filing, up from $100.0 million in the prior quarter.
  • Across five years, Intangibles topped out at $8.2 billion in Q2 2024 and bottomed at $100.0 million in Q3 2023.
  • Average Intangibles over 5 years is $2.3 billion, with a median of $2.1 billion recorded in 2022.
  • Peak YoY movement for Intangibles: soared 877.64% in 2022, then tumbled 95.02% in 2023.
  • A 5-year view of Intangibles shows it stood at $3.1 billion in 2020, then dropped by 27.98% to $2.2 billion in 2021, then dropped by 16.71% to $1.9 billion in 2022, then crashed by 94.59% to $100.0 million in 2023, then skyrocketed by 8132.9% to $8.2 billion in 2024.
  • Per Business Quant database, its latest 3 readings for Intangibles were $8.2 billion in Q2 2024, $100.0 million in Q3 2023, and $1.8 billion in Q1 2023.